Black Diamond Therapeutics Inc (BDTX)

3.06 -0.07 (-2.24%) USD  |  NASDAQ  |  Nov 14, 11:16
More

Black Diamond Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for BDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Regeneron Pharmaceuticals Inc Upgrade
Vanda Pharmaceuticals Inc Upgrade
Ligand Pharmaceuticals Inc Upgrade
Agios Pharmaceuticals Inc Upgrade
ADMA Biologics Inc Upgrade